Conference Home

Scientific Agenda

Accommodations & Travel


Call for Abstracts

13th Canadian Melanoma Conference: Research Frontiers

OncologyEducation is proud present the 13th Canadian Melanoma Conference. The Canadian Melanoma Conference is Canada’s international flagship meeting on the research and treatment of melanoma. This event will take place February 21st-23rd , 2019 at the Fairmont Banff Springs Hotel in Banff, Alberta, Canada.

Target Audience

This conference brings together medical oncologists, surgeons, dermatologists, radiotherapists, pathologists, molecular biologists, immunologists, and other allied health professionals interested in the treatment of melanoma worldwide. 








Nurses/Pharmacists/Allied Healthcare Providers/Residents & Students 



Download the SAVE THE DATE PDF


About the Program Chair

Dr. Scott Ernst, Head, Division of Medical Oncology, London Regional Cancer Program

Program Planning Committee:

Dr. Michael Smylie, Medical Oncologist, Cross Cancer Institute; Professor, Division of Medical Oncology, University of Alberta

Dr. Teresa Petrella, Medical Oncologist, Sunnybrook Odette Cancer Centre; Associate Professor, University of Toronto

Dr. Joel Claveau, Dermatologist, Melanoma and Pigmented Lesions Clini Hôpital Hôtel Dieu de Québec

Dr. Marcus Butler, Medical Oncologist, Princess Margaret Cancer Centre,Clinical Head, Immune-Therapy Profiling Team Assistant Professor, University of Toronto

Dr. J. Gregory McKinnon, Professor of Surgery and Oncology, University of Calgary and Tom Baker Cancer Centre

Dr. Thomas G. Salopek, Associate Professor and Divisional Director, Division of Dermatology and Cutaneous

Science, University of Alberta

Dr. Carman Giacomantonio, Nova Scotia Health, Professor / Surgical Oncologist, Dalhousie University

To download tentative agenda flyer please click here

Other Information

Please direct any questions to Andrea Segal, Senior Event Manager, at

Oncology Clinical News

Surgery May Benefit Some With Early Prostate Cancer: Study

(U.S. News & World Report/HealthDay News) Dec 12, 2018 - For certain men with early prostate cancer, choosing surgery over "watchful waiting" may add a few years to their lives, a new study suggests. European researchers found that among nearly 700 men with earlier-stage prostate cancer, those who received surgery to remove the gland lived three years longer, on average, than those assigned to watchful waiting. However, experts had major caveats about the study, which followed men who were treated for prostate cancer 20 to 30 years ago.
Read full article.

Fetal Tissue Research Targeted by Abortion Foes Inside Administration

Read full article.

Excess Body Weight Responsible For 4% Of Cancers Worldwide, Study Says

(CNN) Dec 12, 2018 - Excess body weight was responsible for 3.9% of cancer globally, or 544,300 cases, in 2012, according to a new report. The new report also highlights a relationship between obesity and the risk of 13 cancers. "Despite numerous studies on the health effects of overweight/obesity (excess body weight), the message has not been well disseminated. In particular, not many people are aware of the link of overweight/obesity to cancer risk," Hyuna Sung, one of the report's authors and a principal scientist at the American Cancer Society, wrote in an email.
Read full article.

Powered by OBR Oncology